EPAS1 and hepatocellular carcinoma: This is consistent with our results, which showed up-regulated HIF-2α expressions of hepatocellular carcinoma cells HepG2 and Huh7 in hypoxic environment, and the overexpression of HIF-2α significantly increased cell viability and reduced sorafenib sensitivity.